Citadel Advisors’s CapForce IBD 50 ETF FFTY Stock Holding History
Bought
Maintained
Sold
Other funds holding FFTY
CPA
IWM
CFP
TRCT
DSCM
Citadel Advisors's FFTY Position: Q1 2026 in Review
Citadel Advisors increased its CapForce IBD 50 ETF (FFTY) stake by 556% in Q1 2026, buying an estimated $1.28M and bringing the position to 40,706 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #6950.
Citadel Advisors first reported a position in FFTY in Q3 2015 and has held it in 33 quarters since. The position peaked at $3.97M in Q3 2021. 39 funds tracked by Wall St. Rank hold FFTY as of Q1 2026.
- Citadel Advisors held 40,706 shares of CapForce IBD 50 ETF worth $1.36M as of Q1 2026.
- Citadel Advisors bought 34,498 CapForce IBD 50 ETF shares in Q1 2026, an estimated $1.28M.
- CapForce IBD 50 ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6950 holding.
- Citadel Advisors first reported a position in CapForce IBD 50 ETF in Q3 2015 and has held it in 33 quarters since.
- Citadel Advisors's CapForce IBD 50 ETF position peaked at $3.97M in Q3 2021.
- 39 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.